![](https://s3.amazonaws.com/cache.altmetric.com/policy/thumbnails/thumbnail-a42b905568edcb7332d0084f7ec650cf9ba802278c055701d5fd75a2af3ce25d.jpg)
Off-Label Use of Intravenous Immunoglobulin for Hematological Conditions: Clinical Effectiveness
Cited by Canadian Agency for Drugs and Technologies in Health on
CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.